Plunkett Research Online: ContraVir Pharmaceuticals Inc

CONTRAVIR PHARMACEUTICALS INC (CTRV:NAS) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

ContraVir Pharmaceuticals Inc is a US-based biopharmaceutical company which is engaged in the development of antiviral drugs with a primary emphasis on the treatment of Hepatitis B virus (HBV) infections. The company focuses on developing two compounds to treat HBV infection i.e. CMX157 which is a p.....



ContraVir Pharmaceuticals Inc
Ticker: CTRV
Exchange: NAS
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 732 902-4000
Fax: 732 902-4100
Address: 399 Thornall Street, First Floor
Edison, NJ 08837 United States

Types Of Business
Industry Ranks

Industry NAICS code:

Pharmaceuticals, Biopharmaceuticals, Generics and Drug Manufacturing
ContactsDescription
James SapirsteinCEO/Director
John CavanCFO/Chief Accounting Officer
See More
ContraVir Pharmaceuticals Inc is a US-based biopharmaceutical company which is engaged in the development of antiviral drugs with a primary emphasis on the treatment of Hepatitis B virus (HBV) infections. The company focuses on developing two compounds to treat HBV infection i.e. CMX157 which is a p.....See More See More

Auditor: BDO USA, LLP
Legal Advisor:
$USD, In whole numbers,
except marked * or %
20172016201520142013
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and AffiliatesTop Salaries
NameTitleSalary (US$)Bonus (US$)
Other ThoughtsCorporate Culture

Apparent Female Officers or Directors: